$YSG

Yatsen (YSG) Q2 2026 Earnings Call Transcript

Yatsen (YSG) reported Q2 2026 net revenue of RMB 1.14B, up 5.1% YoY, driven by skincare growth offsetting color cosmetics decline. Gross margin fell to 73.9% from 78.3% due to inventory provisions. Operating loss widened to RMB 131.9M. Q3 revenue guidance is RMB 898.6M-998.4M, a 0-10% YoY decrease. Management highlighted strategic shifts and industry challenges.

Original reporting
Published Sep 9, 2026, 1:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 9, 2026, 1:34 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Yatsen (YSG) Q2 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$YSGNeutralMed
01

Why it matters

The earnings release provides the first public disclosure of Q2 2026 financials and guidance, offering new data for valuation.

02

Market read

YSG's earnings and guidance affect its valuation and may influence sentiment toward Chinese consumer discretionary stocks.

03

What to watch

Potential cost reductions from SKU rationalization and AI-driven marketing efficiencies could improve margins later.

Relevance 8/10Novelty 8/10Timing: post-earnings release today

Background

Yatsen Holding Limited (ADS: YSG) is a Chinese beauty and personal care company listed in the U.S. as an ADR.

Company-level read

Ticker impact

$YSGNeutralMedium confidence
Context

Yatsen Holding Limited reported Q2 2026 results with 5.1% revenue growth, a widened operating loss and new guidance for Q3 revenue.

Expected impact

Potential short-term downside to test recent support levels, with upside if investors focus on skincare momentum and guidance.

Evidence & confidence

The earnings release provides fresh financial data and guidance, but mixed performance and modest scale suggest limited immediate directional bias.

Market effects

Highlights growth in Chinese skincare segment and challenges in color cosmetics, relevant for beauty sector peers.

Provides insight into Chinese consumer trends and online traffic costs on platforms like Douyin.

Adds data on a foreign ADR, useful for investors tracking emerging market consumer stocks.

Counterpoint

Despite operating losses, the strong skincare revenue share may justify a longer-term bullish stance.

Key entities

  • Jinfeng Huang

    Founder, Chairman and CEO of Yatsen.

  • Donghao Yang

    Chief Financial Officer who is being succeeded by Li Wang.

Related articles

$YSGMed

Yatsen Holding Q2 Loss Widens, Shares Down

Yatsen Holding Ltd. (YSG) reported a wider Q2 2026 loss, with net loss increasing to $13.39M from $17.67M YoY, due to higher expenses. Revenue rose to $168.34M from $108.6M. Shares fell 4.51% premarket. The company forecasts Q3 revenue between $898.6M and $998.4M, a potential YoY decrease of 0% to 10%.

$YSGMed

Yatsen Holding Ltd (YSG): Financial results for Q2 2026

Yatsen Holding Ltd (YSG) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 Yatsen Announces Second Quarter 2026 Financial Results Conference Call to Be Held at 7:30 A.M. U.S. Eastern Time on September 2, 2026 GUANGZHOU, China, September 2, 2026 – Yatsen Holding Limited (“Yatsen” or the “Company”) (NYSE: YSG), a leading China-based beauty gr

$YSGHigh

Yatsen Announces Second Quarter 2026 Financial Results

Yatsen (YSG) reported Q2 2026 revenue growth of 5.1% to $168.3M, driven by a 40.4% increase in skincare sales. Gross margin fell to 73.9% from 78.3% due to higher inventory provisions. Net loss widened to $13.4M from $1.9M. The company is refocusing on high-growth skincare brands.

$YSGHighAI 9/10

Transcript: Yatsen Holding Q1 2026 Earnings Conference Call - Yatsen Holding (NYSE:YSG)

Yatsen Holding reported Q1 2026 results on a conference call. The company said total net revenues rose 22.5% year over year to $1.02 billion, driven by a 58.5% increase from skincare brands, partially offset by a 5% decline in COVID cosmetics. Gross profit rose 24.3% to $819.2 million; gross margin increased to 80.2%. Operating expenses rose 32.5% to $918.1 million, with selling and marketing up to $737.2 million. The company also said it completed a May 21, 2026 closing of a convertible notes/w